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Background: There has been significant progress in identifying genes that confer risk for autism spectrum
disorders (ASDs). However, the heterogeneity of symptom presentation in ASDs impedes the detection of ASD risk
genes. One approach to understanding genetic influences on ASD symptom expression is to evaluate relations
between variants of ASD candidate genes and neural endophenotypes in unaffected samples. Allelic variations in
the oxytocin receptor (OXTR) gene confer small but significant risk for ASDs for which the underlying mechanisms
may involve associations between variability in oxytocin signaling pathways and neural response to rewards. The
purpose of this preliminary study was to investigate the influence of allelic variability in the OXTR gene on neural
responses to monetary rewards in healthy adults using functional magnetic resonance imaging (fMRI).
Methods: The moderating effects of three single nucleotide polymorphisms (SNPs) (rs1042778, rs2268493 and
rs237887) of the OXTR gene on mesolimbic responses to rewards were evaluated using a monetary incentive delay
fMRI task.
Results: T homozygotes of the rs2268493 SNP demonstrated relatively decreased activation in mesolimbic reward
circuitry (including the nucleus accumbens, amygdala, insula, thalamus and prefrontal cortical regions) during the
anticipation of rewards but not during the outcome phase of the task. Allelic variation of the rs1042778 and
rs237887 SNPs did not moderate mesolimbic activation during either reward anticipation or outcomes.
Conclusions: This preliminary study suggests that the OXTR SNP rs2268493, which has been previously identified as
an ASD risk gene, moderates mesolimbic responses during reward anticipation. Given previous findings of
decreased mesolimbic activation during reward anticipation in ASD, the present results suggest that OXTR may
confer ASD risk via influences on the neural systems that support reward anticipation.
Keywords: Autism spectrum disorder (ASD), Oxytocin, Oxytocin receptor, Genetics, Neuroimaging, Reward,
Motivation, Mesolimbic, Functional magnetic resonance imaging (fMRI), Single nucleotide polymorphism (SNP)Background
Autism spectrum disorders (ASDs) are highly heritable
neurodevelopmental disorders [1] and there has been sig-
nificant progress in identifying genes that confer increased
risk for ASDs [2,3]. However, finding clear associations be-
tween genetic risk variants and ASD symptom expression
has been challenging due to the highly heterogeneous nature
of the disorder. One approach to address these challenges* Correspondence: cdamiano@email.unc.edu
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reproduction in any medium, provided the orand improve our understanding of genetic influences on
ASD symptom expression is to evaluate relations between
variants of ASD candidate genes and ASD-relevant neural
endophenotypes in homogeneous unaffected samples
[4]. This imaging-genetics approach has the potential to
elucidate genetic influences on neural endophenotypes
relevant to the expression of ASD symptoms [5].
Although there are hundreds of identified ASD risk
genes [6-8], the oxytocin receptor (OXTR) gene has
been shown to confer a small but significant risk foral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been established across different ethnic populations and
different study methodologies (genome-wide association
studies and linkage analyses) [9-12]. There is also evi-
dence of altered methylation of the OXTR promoter
gene and reduced expression of OXTR in the post-
mortem brains of individuals with ASDs, providing fur-
ther evidence for the role of OXTR, the oxytocin (OXT)
signaling pathway and epigenetic regulation of OXTR in
the etiology of ASDs [13].
OXT is a neuropeptide that has been consistently
linked to affiliative and social behaviors in preclinical
and human studies [14-17]. There is accumulating evi-
dence for the role of altered OXT functioning in the eti-
ology of social impairments in ASDs [18]: atypical levels
of plasma OXT and its precursors have been found in
children with ASDs [19,20] and exogenous OXT admin-
istration has been shown to improve social functioning
in children and adults with ASDs [21-23].
However, the potential mechanisms by which OXT in-
fluences social functioning in ASDs remain poorly
understood. One possibility is via effects of the OXT sig-
naling pathways on mesolimbic brain systems that code
for the motivational relevance of social rewards [24,25].
There has recently been increased interest in examining
the effect of motivational factors on social functioning in
ASDs. The social motivation hypothesis of ASD posits
that disruption of neural mechanisms supporting social
motivation may constitute a primary deficit in ASDs
with potential downstream effects on the development
of social cognition [26,27]. This model is supported by
initial neuroimaging evidence for attenuated neural re-
sponses to social rewards in mesolimbic brain regions in
ASDs [28,29], though there is evidence of altered meso-
limbic functioning in response to non-social rewards in
ASDs as well [30,31].
Brain regions that code for reward valuation, including
the nucleus accumbens and amygdala, have dense OXTR
expression [32,33] and OXT binding in these regions in-
fluences social behaviors [34-39]. Additionally, OXT
plays a key role in regulating dopaminergic activity in
mesolimbic reward circuitry [40-43]. Infusion of an
OXT agonist into the ventral tegmental area results in
increased dopaminergic neuron firing in the ventral stri-
atum in a manner that predicts variability in maternal
behavior [41], and administration of intranasal OXT en-
hances mesolimbic activation in response to social re-
wards (for example, viewing a smiling infant face) [44,45].
Additionally, plasma levels of OXT are associated with
variability in ventral and dorsal striatal activation during
reciprocated cooperation, a socially rewarding experience
[45,46]. Variants of the OXTR gene are associated with
structure and function of reward-related brain regions, in-
cluding the hypothalamus, insula and amygdala [47-49].These studies suggest that OXT may stimulate mesolimbic
dopamine release, which may thereby facilitate approach
behaviors towards rewards [50].
Despite the central role of OXT systems for social mo-
tivation and evidence for OXT binding in mesolimbic
reward-processing brain regions, no study to date has
examined the effects of individual differences in OXT
functioning on mesolimbic responses to rewards. The
present study examined how allelic variants of the
OXTR gene influence neural responses to rewards dur-
ing functional magnetic resonance imaging (fMRI). To
index the neural substrates of reward processing, we
used a monetary incentive delay (MID) task [51] that re-
liably recruits reward-processing circuitry across a wide
range of clinical and non-clinical populations [52-59].
This preliminary investigation addressed only responses
to monetary rewards since we were primarily interested
in testing the hypothesis that OXTR variants are gener-
ally associated with dopaminergic mesolimbic activation
and monetary rewards are a common laboratory proxy
for primary rewards that are known to activate mesolim-
bic brain regions robustly [60].
Three OXTR single nucleotide polymorphisms (SNPs)
were examined (rs1042778, rs2268493 and rs237887),
each of which has previously been linked to individual
differences in social functioning and ASD risk. The
rs1042778 SNP has been associated with ASD risk as
well as the severity of social impairments in ASDs [10],
prosocial decision-making in typical controls [61], and
social-communicative abilities in individuals with ASDs
and their families [62]. The rs2268493 SNP has been
linked to increased risk for ASDs and increased social
impairment, communicative symptoms and restricted
and repetitive behaviors in ASDs [9,10]. Finally, the
rs237887 SNP has been associated with prosocial
decision-making [61] and empathy [63] in typical con-
trols and has been associated with an increased risk of
ASDs in the Japanese population [64]. Our overarching
hypothesis was that OXTR alleles previously linked to
ASD risk or impaired social functioning would be associ-
ated with attenuated mesolimbic activation during reward
anticipation specifically. This hypothesis is based on the
regulatory effects of OXT specifically on striatal dopamine
[40-43], which is a central neurotransmitter that codes for
the motivational salience of anticipated rewards [65].
Methods
Participants
Initially, 41 healthy adults who had participated in a
prior imaging-genetics study at Duke University were
contacted to participate. Of these, 36 participants com-
pleted the fMRI scan, and five of these were excluded
due to unusable genetic information, resulting in a final
sample of 31 participants (14 male, see Table 1 for
Table 1 Participant characteristics
Characteristic Mean Standard deviation Range
Age 23.58 3.15 19 to 31
Full scale IQa 109.41 2.46 103.75 to 112.40
Verbal IQa 107.98 2.88 100.96 to 112.68
Performance IQa 109.62 1.36 106.31 to 111.84
SCL-90-R GSIb 0.18 0.14 0.02 to 0.47
AQc 13.03 5.85 2 to 26
Sex 17 female, 14 male
aEstimated from the National Adult Reading Test – Revised (NART-R).
bGSI, Global Severity Index; IQ, intelligence quotient; SCL-90-R, Symptom
Checklist-90-Revised (clinical cut-off = 2.49 [68]). cAQ, autism
spectrum quotient.
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were not taking any psychotropic medications and had no
current or past psychiatric disorders according to the Struc-
tured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I) [66], which was administered by a trained inter-
viewer and supervised by a licensed psychologist. All partic-
ipants scored below the clinical cut-off for the Symptom
Checklist-90-R (SCL-90-R) [67,68], a general measure
of clinical distress or psychopathology. Participants also
completed the National Adult Reading Test – Revised
(NART-R). Intelligence quotient (IQ) [69] and the autism
spectrum quotient [70], a continuous measure of autism
symptomatology, were estimated. To minimize effects of
population stratification, the sample included only non-
Hispanic Caucasian participants. This study was reviewed
and approved by the Duke University Institutional Review
Board and written informed consent was obtained from all
participants.
Genotyping
The Oragene DISCOVER (OGR-250) collection kit
(formerly known as the Oragene DNA collection kit)
(DNA Genetic Inc, Kanata, ON, Canada) was used to
obtain genetic information. All participants provided at
least 5 mL of saliva for the genetic sample. DNA was
isolated using QIAGEN Autopure LS (Venlo, The
Netherlands). As part of a larger study investigating a
custom set of SNPs, genotyping was performed by the
Center for Human Genome Variation at Duke University
using a GoldenGate assay with the Illumina BeadXpress
platform (Illumina, Inc, San Diego, CA, USA).
This procedure provided allelic information for the
following OXTR SNPs: rs53576, rs237885, rs237887,
rs237900, rs1042778, rs2254295, rs2268493, rs4686301,
rs9840864 and rs11131149. The available OXTR variants
with intact SNP data (call rates >0.9) for all 31 participants
included four SNPs: rs237887, rs1042778, rs2254295 and
rs2268493. From these four SNPs, three SNPs (rs1042778,
rs2268493 and rs237887) were selected based on minor allele
frequencies >0.20 in the present sample (the minor allelefrequency for the rs2254295 SNP was 0.12). These three
SNPs have also been associated with individual differences in
social functioning and/or ASD risk in previous studies. For
example, see [9,10,62]. Allelic frequencies in these SNPs were
similar to the minor allele frequency expected in Caucasian
samples and were consistent with Hardy–Weinberg equilib-
rium (rs2268493: χ2 = 0.03; rs1042778: χ2 = 0.03; rs237887:
χ2 = 0.05, in the present sample).
Across all SNPs, risk allele homozygotes were com-
pared to a combined group of non-risk allele homozy-
gotes and heterozygotes. For rs2268493, the T allele has
been associated with ASD risk [9,10], and thus we com-
pared 14 risk allele homozygotes (TT) to a combined
group of 17 non-risk allele homozygotes and heterozy-
gotes (CC/CT). For rs237887, the A allele has been
linked to increased risk for ASD in the Japanese popula-
tion [64] as well as decreased prosociality [61], and thus
we compared nine risk allele homozygotes (AA) to a
combined group of 22 heterozygotes and non-risk allele
homozygotes (AG/GG). For rs1042778 the G allele has
been linked to ASD risk [10,62], and thus we compared
14 risk allele homozygotes (GG) to 17 non-risk allele ho-
mozygotes and heterozygotes (TT/TG).
Participants included in the current study were drawn
from a larger sample, which included 508 Caucasian par-
ticipants. To evaluate potential linkage disequilibrium
among the three OXT SNPs examined in the present
study (rs1042778, rs2268493 and rs237887), we calcu-
lated linkage disequilibrium in the larger sample from
which these participants were drawn. These SNPs were
not in linkage disequilibrium in this larger sample, since
in all cases r2 < 0.64:
 rs1042778 and rs2268493: r2 = 0.078
 rs1042778 and rs237887: r2 = 0.291
 rs2268493 and rs237887: r2 = 0.211
 rs2268493 and rs1042778: r2 = 0.078
 rs237887 and rs1042778: r2 = 0.291
 rs237887 and rs2268493: r2 = 0.211
These were consistent with linkage disequilibrium
values from the HapMap website [71].
fMRI task
Participants completed two runs of a monetary incentive
delay (MID) task [57] as part of a 1-hr-long fMRI scan
session. During this scan session, the participants also
completed two runs of an unrewarded go/no-go task.
The MID task and the go/no-go task were presented in
a pseudo-randomized, counterbalanced order, and only
the results of the MID task are presented here.
Each MID trial consisted of: (1) a 2,000-ms cue indi-
cating whether a monetary reward could be won (a tri-
angle) or not (a circle) on a given trial; (2) a 2,000 to
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sented for up to 500 ms that required a speeded button
press; (4) 3,000 ms of feedback to indicate if the partici-
pant gave a sufficiently fast response and (5) a variable
length inter-trial interval crosshair. The total duration of
the trial was 12 s. For trials in which a monetary reward
was possible (incentive trials), a sufficiently fast response
resulted in the presentation of an image representing a
gain of $1 per successful trial, whereas a slower response
resulted in presentation of an ‘X’ indicating that no
money had been won. For trials in which a monetary re-
ward was not possible (non-incentive trials), the partici-
pants were still instructed to respond as quickly as
possible to the bullseye image. During these non-
incentive trials, a sufficiently fast response resulted in
the presentation of a checkmark symbol indicating a
successful response and no monetary gain, whereas a
slower response resulted in the presentation of an ‘X’ in-
dicating an unsuccessful response and no monetary gain.
Potential reward and non-reward trials were aperiodic
and pseudo-randomly ordered. Each run included 40 trials
(50% reward trials, 50% non-reward trials). The partici-
pants were instructed to try to be successful on as many
trials as possible, and that success was contingent on re-
sponse times. The response time threshold for a reward
trial was adaptive to individual differences in response
times so that all participants were successful for approxi-
mately two-thirds of trials (that is, approximately 66.67%
accuracy; actual average accuracy was 66.85%, SD = 0.04).
All stimuli were presented using E-Prime presentation
software (Psychology Software Tools Inc, Pittsburgh,
PA, USA) and were viewed through magnet-compatible
goggles (Resonance Technology Inc, Northridge, CA,
USA).
fMRI collection and analysis
Scanning was performed with a General Electric Health
Technologies 3-T MR750 scanner (General Electric,
Waukesha, WI, USA) with 50-mT.m-1 gradients at a
200 T.m-1.s-1 slew rate. Foam cushions were placed
around the head to minimize motion. A 32-channel head
coil was used for parallel imaging with a sparse matrix
in k-space [72] to correct for geometric distortions with-
out the need for an additional field mapping sequence.
High-resolution structural images with 162 slices were
acquired using a three-dimensional fast SPGR BRAVO
pulse sequence (repetition time: 7.584 ms; echo time:
2.936 ms; field of view: 256 mm; image matrix: 256 ×
256; voxel size: 1 mm3; flip angle: 12º) and used for co-
registration with the functional data. Structural images
were aligned in the near-axial plane defined by the anter-
ior and posterior commissures. Whole-brain functional
images consisted of 32 interleaved slices parallel to the an-
terior and posterior commissure plane using a SENSEspiral pulse sequence sensitive to blood oxygenation level
dependent (BOLD) contrast (repetition time: 2000 ms;
echo time: 30 ms; field of view: 24 cm; image matrix: 64 ×
64; voxel size: 4 mm3; flip angle: 77º). All runs began with
four discarded radio-frequency excitations to achieve
steady-state equilibrium. No participant had greater than
3 mm movement in the x, y or z dimension.
Functional data were preprocessed using FEAT (FMRI
Expert Analysis Tool) [73,74] from FMRIB's software li-
brary (FSL) (www.fmrib.ox.ac.uk/fsl). Preprocessing for all
functional data involved the following steps: (1) brain ex-
traction to remove all non-brain data [75]; (2) motion cor-
rection using MCFLIRT [76]; (3) spatial smoothing using
a Gaussian kernel of full width half maximum 5 mm; (4)
mean-based intensity normalization of all volumes by the
same factor and (5) high-pass temporal filtering to remove
slow signal drift (60 s) [76]. Functional and structural im-
ages were co-registered in native space and normalized to
a standard stereotaxic space (using Montreal Neurological
Institute templates). All registrations were carried out
using the FMRIB Linear Image Registration Tool (FLIRT)
for linear registration (affine with 12 degrees of freedom).
The same transformation matrices used for structural-to-
standard transformations were then used for functional-
to-standard space transformations of the co-registered
functional images. Registrations were applied using an
intermodal registration tool [74,76] and voxel-wise tem-
poral autocorrelation was estimated and corrected using
FMRIB's Improved Linear Model [77].
Initial analyses examined task effects in the entire
group to verify the activation of the hypothesized meso-
limbic reward circuitry by the task. Next, the primary re-
search questions were addressed by examining the
moderating effects of allelic group on task-specific brain
activation. Data from anticipation and outcome phases
were analyzed separately. During the anticipation phase
(the time between presentation of cues and potential re-
ward receipt), the contrast of interest was the effect of
allelic group on differences in brain activation for incen-
tive versus non-incentive trials. During the outcome
phase (during presentation of feedback), the contrast of
interest was the effect of allelic groups on differences in
brain activation for reward versus non-reward trials.
Models were evaluated separately for each of the three
SNPs examined.
A double-γ function modeled the hemodynamic re-
sponse for each event type (incentive/non-incentive tri-
als and reward/non-reward trials) in each run. Using a
fixed-effects general linear model, parameter estimates
from the two runs from each participant were combined.
These data were then used in a random-effects analysis
to compare allelic groups, using FMRIB Local Analysis
of Mixed Effects (FLAME) [75,78]. Initial whole-brain
analyses examining task effects in the entire sample used
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corrected cluster significance threshold of P < 0.05.
This somewhat high Z threshold was used to allow
visualization of effects primarily in reward-processing re-
gions. For the analyses involving the three individual
SNPs, whole-brain analyses were conducted using Z
statistic images thresholded at Z > 3.0 with a corrected
cluster significance threshold of P < .05 / 3 = 0.0167. Ac-
tivation localizations were based on Harvard–Oxford
cortical and subcortical structural probabilistic atlases,
as implemented in FSLView v3.1.8.
Results
Genotypic and sex effects on demographic and
behavioral data
Potential demographic differences between allelic groups
were examined for each SNP. Across all three SNPs, there
were no group differences in age, sex ratios, estimated IQ
(performance, verbal or full scale) or general clinical
symptomatology (based on SCL-90 scores), P > .16. There
were also no significant differences between allelic groups
in response times during the scanner task, P > .20 (see
Figure 1). In addition, there were also no significant sex
differences on any of these demographic variables, P > .06,
and there were no significant sex differences in response
times, P > .83. The mean response time across all partici-
pants was 212.70 ms (SD = 31.37).
fMRI data: anticipation phase
Entire sample
Across the entire sample, regardless of allelic group, reward
anticipation activated the bilateral nucleus accumbens as
well as other reward-processing regions, including the
right caudate, right amygdala, left insular cortex, rightFigure 1 Response times (in ms) during incentive trials of the
monetary incentive delay (MID) task for different oxytocin
receptor (OXTR) gene single nucleotide polymorphisms (SNPs)
grouped based on rs2268493, rs237887 and rs1042778 allelic
variants. OXTR, oxytocin receptor; SNP, single nucleotide
polymorphism.thalamus, right anterior cingulate gyrus and left orbital
frontal cortex (see Table 2 and Figure 2). Table 2 shows
activation during incentive versus non-incentive trials
of the anticipation phase of the MID task across the en-
tire sample (thresholded at Z > 5.25, corrected cluster
significance threshold of P < .05).rs2268493
During reward anticipation, activation was decreased in
risk allele homozygotes (TT) relative to the combined
group of heterozygotes and non-risk allele homozygotes
(TC/CC) in the left nucleus accumbens, left orbital
frontal cortex, right amygdala, bilateral insular cortex,
left thalamus and left anterior cingulate gyrus (see
Figure 3a and Table 3). Table 3 shows differences in
brain activation between allelic groups for the rs2268493
SNP (that is, TT < CC/CT) for incentive versus non-
incentive trials during the anticipation phase of the MID
task (thresholded at Z > 3.0, corrected cluster signifi-
cance threshold of P < .05/3 = 0.0167). No regions showed
relatively greater activation for the risk allele homozygotes.
These general linear model analyses were then followed up
with permutation testing using FSL Randomise to verify
allelic differences in key regions of interest. As illus-
trated in Figure 3b, permutation testing validated the
central finding of decreased activity in the left nu-
cleus accumbens and anterior cingulate gyrus.rs237887
Allelic variation of the rs237887 SNP (that is, risk allele
homozygotes versus the combined heterozygotes and
non-risk homozygotes group) did not significantly influ-
ence activation in mesolimbic regions (see Figure 4 and
Table 4). Table 4 shows differences in brain activation
between allelic groups for the rs237887 SNP (that is,
AA < AG/GG) for incentive versus non-incentive trials
during the anticipation phase of the MID task (thre-
sholded at Z > 3.0, corrected cluster significance thresh-
old of P < .05/3 = 0.0167).rs1042778
Allelic variation of the rs1042778 SNP (that is, risk allele
homozygotes versus the combined heterozygotes and
non-risk homozygotes group) did not significantly influ-
ence activation in mesolimbic regions.fMRI data: outcome phase
Allelic variations in the rs2268493, rs237887 and rs1042778
SNPs did not moderate activation of mesolimbic regions
during reward outcomes (see Additional file 1 for outcome
phase results).
Table 2 Activation during incentive versus non-incentive trials
Montreal Neurological Institute coordinates
Brain region Voxels Z (maximum) x y z
Left accumbens 104 6.60 −10 10 −8
Right accumbens/right caudate 57 6.27 8 4 −2
Right amygdala 16 5.65 14 2 −16
Right anterior cingulate gyrus 693 6.73 6 16 34
Right brainstem 386 6.72 8 −28 −18
Left orbital frontal cortex 19 5.74 −34 24 −6
Left insular cortex 82 6.20 −38 14 −8
Right intracalcarine cortex 97 6.47 18 −68 10
Left juxtapositional lobule cortexa 55 5.92 −2 0 70
Right lateral occipital cortexa 12 6.00 34 −88 −18
Left lingual gyrus 96 6.17 −14 −56 −6
Left occipital pole 67 6.53 −22 −96 16
Right precentral gyrus 22 5.58 44 2 46
Left posterior cingulate 17 5.78 −2 −24 26
Right thalamus 266 7.09 4 −4 2
aTwo clusters within same region, coordinates and peak activation reported for highest peak activation.
Damiano et al. Molecular Autism 2014, 5:7 Page 6 of 12
http://www.molecularautism.com/content/5/1/7Discussion
The purpose of this study was to investigate whether al-
lelic variations of OXTR SNPs influence mesolimbic
brain activation during reward processing. We found
that allelic variations in rs2268493, but not rs237887 or
rs1042778, were related to mesolimbic activation dur-
ing reward anticipation, but not reward outcomes, in
healthy adults. The regions moderated by this OXTR
SNP, including the nucleus accumbens, amygdala, thal-
amus, insula, orbital frontal cortex and anterior cingu-
late gyrus, have been consistently linked to reward
motivation. For reviews, see [79,80]. In contrast to
brain activation findings, no differences between allelic
groups were observed in behavioral responses duringFigure 2 Brain regions showing significant activation for incentive ve
monetary incentive delay task across the entire sample. Z values indic
nucleus accumbens.the MID task. These findings suggest a disconnect be-
tween behavioral and neural responses and that the ef-
fects of rs2268493 variations are relatively weaker at
the level of behavior than at the level of brain-based
endophenotypes [81,82].
The association between rs2268493 and mesolimbic
response during reward anticipation is consistent with
preclinical evidence that the OXT and mesolimbic dopa-
mine systems act reciprocally and become linked
through early social experiences [40,42,43,83-85] and
that OXT modulation may directly result in increased
firing of dopaminergic neurons in the ventral striatum
[41]. Additionally, in humans, exogenous OXT adminis-
tration influences mesolimbic responses to social stimulirsus non-incentive trials during the anticipation phase of the
ate cluster thresholds. ACG, anterior cingulate gyrus; L, left; NAcc,
Figure 3 Brain regions showing significantly reduced activation for the OXTR SNP rs2268493 risk allele group during the anticipation
phase of the monetary incentive delay task using both a general linear model approach and permutation testing. (a) General linear
model analyses (in red). Z values indicate cluster thresholds. (b) Randomize permutation testing analysis (in blue). Note the convergence of
effects in the left NAcc and ACG. ACG, anterior cingulate gyrus; L, left; NAcc, nucleus accumbens; OXTR, oxytocin receptor; PCG, paracingulate
gyrus; SNP, single nucleotide polymorphism.
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striatal responses to a social reward (that is, reciprocated
cooperation) [45,46].
Understanding the moderating effects of the OXTR
gene in the general population may guide the study of
genetic mechanisms underlying motivation deficits inTable 3 Differences in brain activation between allelic groups
Brain region Voxels Z (maximum)
Left accumbens 83 4.26
Right amygdala 65 4.03
Left anterior cingulate gyrusa 419 4.93
Brainstem 16 4.24
Left orbital frontal cortexa 10 3.4
Left insular cortexa 59 3.87
Right insular cortex 108 3.66
Left middle frontal gyrus 21 3.43
Left occipital fusiform gyrus 147 4.5
Posterior cingulate 11 3.51
Right superior frontal gyrusa 41 3.84
Left thalamus 134 4.58
aTwo clusters within same region, coordinates and peak activation reported for higASDs (cf. [92]). This approach of examining the effects
of gene variants irrespective of clinical diagnosis can be
informative given that risk alleles related to a particular
disorder may have a more direct influence on relevant
neurobiological endophenotypes than the disorder itself
[81]. Thus, gaining an understanding of the effects ofMontreal Neurological Institute coordinates
x y z
−10 10 −10
12 −4 −18
−4 24 24
0 −22 −20
−32 20 −22
−32 22 0
38 14 −10
−34 10 32
−30 −84 −22
0 −44 4
10 2 66
−6 −4 −2
hest peak activation.
Figure 4 Brain regions showing significantly reduced activation for the OXTR SNP rs237887 risk allele group the during the
anticipation phase of the monetary incentive delay task. Z values indicate cluster thresholds. L, left; MFG, middle frontal gyrus; OXTR,
oxytocin receptor; SNP, single nucleotide polymorphism.
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parse the neurobiological heterogeneity of complex neu-
rodevelopmental disorders, such as ASDs [4].
Given the heterogeneity of ASDs and given that hun-
dreds of different genes may be implicated in ASDs with
each contributing small degrees of risk [2,92-94], it is
important to emphasize that the clinical generalizability
of the present findings is contingent on future studies
examining the moderating influence of OXT on the
mesolimbic response to rewards in individuals with
ASDs. In addition, it is important to note that a compre-
hensive account of candidate molecular genetic influences
on brain function in ASDs will require a systems-level ap-
proach that accounts for gene–gene interactions, the in-
fluence of epistasis and epigenetics on multiple neural
networks and the pleiotropic effects of genes on neural
phenotypes [95]. Additionally, the present study examined
only mesolimbic responses to monetary rewards whereas
ASDs have been associated with atypicalities in the pro-
cessing of both social and non-social rewards [96]. Further
research will be necessary to address OXT modulation of
mesolimbic responses to social rewards, as suggested byTable 4 Differences in brain activation between allelic groups
Brain region Voxels Z (maxim
Left inferior frontal gyrus (pars opercularis) 27 3.47
Right lateral occipital cortex 27 3.74
Right lateral occipital pole 12 3.36
Right lingual gyrus 20 3.79
Left middle frontal gyrusa 39 3.81
Right occipital fusiform gyrus 68 3.6
Right occipital pole 65 4.44
Right precuneus 36 3.92
Left supramarginal gyrus (posterior) 60 3.55
aTwo clusters within same region, coordinates and peak activation reported for higalternative models of oxytocinergic function (for example,
[97,98]), and to compare directly the effects of OXTR
genes on social and non-social reward motivation in
ASDs.
We also note that caution is warranted when inter-
preting null findings during the outcome phase of the
task given the use of a recessive genetic model (that is,
comparing risk allele homozygotes with other partici-
pants). This model was chosen because it is a more con-
servative test of the effects of the risk allele on the
neural endophenotype and because our sample did not
have sufficient numbers of non-risk allele carriers for
meaningful analyses that compared risk allele carriers
versus non-risk homozygotes (for rs2268493, only two
participants were not T-allele carriers).
An important limitation of the present study was the
relatively modest sample size, particularly in light of a
number of recent non-replications of neuroimaging gen-
etics studies [99]. Thus it may be that modestly sized
samples in the context of candidate-gene studies are
underpowered [100]. Further, a recent meta-analysis failed
to confirm relations between OXTR SNPS rs53576 andMontreal Neurological Institute coordinates
um) x y z
−54 14 10
48 −72 −2
36 −84 16
8 −86 −12
−28 32 44
14 −78 −14
12 −94 16
6 −56 40
−50 −42 46
hest peak activation.
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replication will be necessary to draw firm conclusions
about the role of rs2268493 in reward motivation. How-
ever, consistent with recommendations for imaging genet-
ics studies [102], we used a well-validated fMRI task that
had previously shown robust effects and significant vari-
ance in the typical population [103] and participants in
the present study were homogeneous in terms of racial
and ethnic background, age, IQ and mental health status.
Although this sampling strategy limits the generalizability
of results, it helps to control for the effects of these non-
genetic factors [102]. It is also important to note that
OXTR may not be directly related to reward motivation,
but rather this relation may be mediated by other func-
tions of the OXT system, such as anxiolytic effects (for ex-
ample, [38,104]) or effects on memory (for example,
[105]). Additionally, the activation clusters associated with
allelic differences in rs2268493 were not confined to
mesolimbic regions but rather included several regions
that are not commonly associated with reward motivation
(for example, the brainstem and superior frontal gyrus).
Although such findings, which were not hypothesized, in-
dicate that the moderating effects of rs2268493 may not
be constrained to mesolimbic regions, future studies will
be needed to replicate these results.
Conclusions
Despite these limitations and interpretive cautions, this
study is a preliminary step towards a better understand-
ing of the potential genetic mechanism underlying indi-
vidual differences in neural activation during reward
motivation, which may ultimately contribute to our un-
derstanding of dysfunctional motivational systems in
ASDs. Although identifying brain functions associated
with specific genes is an important early step in under-
standing the effects of particular ASD risk genes on
ASD symptom expression, the link between a single
gene and brain function will ultimately only explain a
small part of the complex genetic heterogeneity of ASDs
[97]. A systems approach to studying genetic and brain
imaging data will be necessary for integrating informa-
tion about the effects of multiple alleles on multiple
genes, multigenic interactions on neural networks, pleio-
tropic effects of genes on cognitive, affective, and motor
development, and the influence of environmental and
epigenetic factors on these processes.
Additional file
Additional file 1: fMRI results from the outcome phase of the
monetary incentive delay task. This document details the results of
analyses involving brain activation during the outcome phase of the
monetary incentive delay task for the entire sample and each of the
three SNPs (rs2268493, rs1042778 and rs237887). Tables displaying theregions with significant activation during the outcome phase for the
entire sample and for the SNP rs237887 are also included.
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